إعلان مُمول
Japan’s Pioneering ASO Drugs Showcase Domestic Innovation Strength
The global oligonucleotide therapy market reached around USD 8.6 billion in 2023 and is projected to soar to approximately USD 30.5 billion by 2031, reflecting a spectacular 15.8% CAGR during 2024–2031. Mid range forecasts project growth from USD 5.6 billion (2024) to nearly USD 9.8 billion (2029) a 12–14% CAGR   highlighting a robust and multi‑year expansion trajectory. Sample...
0 التعليقات 0 المشاركات 19 مشاهدة 0 معاينة
إعلان مُمول
إعلان مُمول
إعلان مُمول